omation mbers - Society for Laboratory Automation and Screening
omation mbers - Society for Laboratory Automation and Screening
omation mbers - Society for Laboratory Automation and Screening
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
TP050<br />
Lynn Hilt<br />
The Ashvins Group, Inc.<br />
Bio IT Professionals<br />
8390 N W 53rd Street, Suite 200<br />
Miami, Florida 33166<br />
jberlin@ashvinsgroup.com<br />
Software Validation <strong>for</strong> Aut<strong>omation</strong> Projects<br />
171<br />
Co-Author(s)<br />
Terry Weeks<br />
Thoroughly characterized <strong>and</strong> dependable software is a critical component of laboratory aut<strong>omation</strong> projects. The<br />
use of software to automate <strong>and</strong> streamline laboratory operations include projects that 1) automate laboratory<br />
procedures with robotic systems; 2) consolidate data collection <strong>and</strong> analysis; 3) manage <strong>and</strong> share data collected<br />
from sophisticated drug discovery or clinical research processes <strong>and</strong>/or 4) interface instruments, systems <strong>and</strong><br />
software. Often these projects involve custom applications or modifications of Off-the-Shelf (OTS) software<br />
products. It is clear that these systems must satisfy Good <strong>Laboratory</strong> Practices (GLP) requirements, but the<br />
scope <strong>and</strong> methods employed to validate computer related systems is highly subjective.Validation of computer<br />
related systems is often complex, <strong>and</strong> alternate approaches may be used. The appropriate validation ef<strong>for</strong>t will<br />
depend upon various factors, including the complexity of the system, intended use of the system, <strong>and</strong> whether the<br />
functions are critical or non-critical in the aut<strong>omation</strong> project. This poster identifies factors to be considered <strong>and</strong><br />
steps to be taken in validation of Computer Related Systems used in GLP environments.Validation technology may<br />
be addressed through a variety of testing <strong>for</strong>mats such as:<br />
• Installation <strong>and</strong> Operational Qualification (IQ/OQ)<br />
• Off-the-Shelf Software (OTS) Validation<br />
• Custom Software Validation <strong>and</strong> Verification (V&V)<br />
In conclusion, pertinent validation testing <strong>and</strong> documentation are required to demonstrate proper per<strong>for</strong>mance of<br />
Computer Related Systems used to support laboratory aut<strong>omation</strong> projects.<br />
TP051<br />
R<strong>and</strong>all Hoffman<br />
Invitrogen Corporation<br />
<strong>Screening</strong> Applications<br />
501 Charmany Drive<br />
Madison, Wisconsin 53719<br />
r<strong>and</strong>y.hoffman@invitrogen.com<br />
Co-Author(s)<br />
Gerald Habenbacher, Tecan Austria<br />
Ion Channel Assay Development Using Voltage Sensor Probes on the GENios Pro<br />
Multifunctional Reader From Tecan<br />
Ion channels are important drug targets because of their critical role in nerve, cardiac, endocrine, <strong>and</strong> skeletal<br />
muscle tissues. The lack of sufficiently sensitive, high throughput screening systems has hampered research<br />
in this area. Voltage Sensor Probes (VSP) technology can be used with any ion channel target that changes<br />
membrane potential, <strong>and</strong> is there<strong>for</strong>e well suited <strong>for</strong> sodium, potassium, calcium, chloride, <strong>and</strong> lig<strong>and</strong>-gated ion<br />
channel research. The FRET-based detection method provides ratiometric results which significantly reduces errors<br />
arising from well-to-well variations in cell number, dye loading <strong>and</strong> signal intensities, plate inconsistencies, <strong>and</strong><br />
temperature fluctuations. These combined features make VSP technology highly amenable <strong>for</strong> high throughput<br />
screening (HTS) applications. Assay development <strong>and</strong> therapeutic groups develop <strong>and</strong> validate ion channel assays<br />
prior to HTS <strong>and</strong> may have lower throughput instrumentation that may or may not be amenable to VSP technology.<br />
This abstract demonstrates the use of Tecan’s GENios Pro instrument as a suitable plat<strong>for</strong>m <strong>for</strong> development of<br />
VSP ion channel assays in both the pharmaceutical <strong>and</strong> academic environments.<br />
POSTER ABSTRACTS